Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 906026, 6 pages
http://dx.doi.org/10.1155/2015/906026
Research Article

Role of the Aspartate Transaminase and Platelet Ratio Index in Assessing Hepatic Fibrosis and Liver Inflammation in Adolescent Patients with HBeAg-Positive Chronic Hepatitis B

1Department of Infectious Diseases and Shenzhen Key Lab for Endogenous Infection, Shenzhen Nanshan Hospital, Guangdong Medical College, No. 89, Taoyuan Road, Nanshan District, Shenzhen 518052, China
2Department of Gastroenterology, The Central Hospital of Wuhan, No. 26, Jianghan Road, Wuhan, China
3Institute of Infectious Diseases and Medical Center for Liver Failure, Beijing 302 Hospital, Beijing, China
4Department of Liver Diseases, Huizhou Municipal Central Hospital, No. 41 Eling North Road, Huizhou, China

Received 17 March 2015; Revised 11 June 2015; Accepted 14 June 2015

Academic Editor: John N. Plevris

Copyright © 2015 Yu Zhijian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Answer: Table S1: Univariate analysis of variables associated with significant liver fibrosis in 88 adolescent patients with CHB. In this table, the clinical indicators including ALB, PLT, gender, age, total bilirubin (TBIL), APRI, Prothrombin time activity(PTA),ALB, Log10(HBV DNA), cholinesterase (CHE) were investigated with univariate analysis between 45 cases with mild liver fibrosis (S1) and 43 with significant liver fibrosis (≥ S2).

Table S2: Univariate analysis of variables associated with significant liver inflammation in 88 adolescent patients with CHB. In this table, the clinical indicators including ALB, PLT, gender, age, total bilirubin (TBIL), APRI, Prothrombin time activity(PTA), ALB, Log10(HBV DNA), cholinesterase (CHE) were investigated with univariate analysis between 31 patients with mild liver inflammation (G1) and 57 patients with significant liver inflammation (≥ G2).

  1. Supplementary Material